FDA•LOW
Lidolog Kit
Lidolog Kit is being recalled because the label wrap obscures the barcode, making it difficult to scan.
Filters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•LOWFexofenadine Hydrochloride Tablets 180 mgOhm Laboratories is recalling 180 mg Fexofenadine Hydrochloride tablets due to failed impurities and degradation specifications.
FDA•CRITICALDiclofenac Sodium 0.1% Eye OintmentMFV Compounding Pharmacy is recalling Diclofenac Sodium 0.1% Eye Ointment due to potential Bacillus cereus contamination.
FDA•LOWHydroxyzine Hydrochloride Oral SolutionANI Pharmaceuticals is recalling Hydroxyzine Hydrochloride Oral Solution, 10 mg/5 mL, due to the presence of a foreign substance.
FDA•LOWFocalin XR 5 mg CapsulesSandoz is recalling Focalin XR 5 mg capsules due to missing or incorrect lot numbers and expiration dates on the product labels.
FDA•LOWPrimidone 50 mg TabletsAmneal Pharmaceuticals is recalling Primidone 50 mg tablets due to potential cross-contamination with Acemetacin API.
FDA•CRITICALBeekeeper's Naturals Saline Nasal SprayBeekeeper's Naturals is recalling 1 FL OZ Saline Nasal Spray bottles due to potential microbial contamination.
2 products
FDA•CRITICALCareFusion 213: Multiple Chlorhexidine Gluconate ProductsCareFusion recalls BD ChloraPrep Clear and FREPP Clear applicators over sterility concerns from lidding wrinkles.
4 products
FDA•LOWEpinephrine Injection 1mg/mLFresenius Kabi is recalling Epinephrine Injection 1mg/mL vials due to out-of-specification stability test results.
FDA•CRITICALDoxorubicin Hydrochloride Liposome InjectionNorthstar Rx is recalling Doxorubicin Hydrochloride Liposome injection 50 mg/25 mL vials due to potential glass particulate contamination.
FDA•CRITICALHaleon US: multiple drugsHaleon is recalling Gas-X Extra Strength softgels in 72-count and 120-count packages due to potential chemical contamination.
2 products
FDA•LOWLidocaine HCl Injection 2%Eugia US LLC is recalling Lidocaine HCl Injection 2% because the label wrap covers the barcode, making it difficult to scan.
FDA•LOWPred Mild Ophthalmic SuspensionAbbVie is recalling 10 mL bottles of Pred Mild ophthalmic suspension due to failed stability specifications.
FDA•LOWNicotine Transdermal System Patch 14 mgAveva is recalling 14 mg Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities.
FDA•LOWPrimidone Tablets 250 mgAmerican Health Packaging recalls Primidone 250 mg tablets over API cross contamination.
2 products
FDA•LOWBusulfan InjectionSagent Pharmaceuticals is recalling Busulfan Injection (NDC 25021-241-10) due to failed impurities and degradation specifications.
FDA•LOWPrimidone Tablets 50 mgGolden State Medical Supply is recalling Primidone Tablets 50 mg due to cross-contamination with trace amounts of Acemetacin API.
2 products
FDA•LOWPrimidone 250mg TabletsLannett Company is recalling Primidone 250mg Tablets (NDC 0527-1231-01) due to potential cross-contamination with Acemetacin API.
FDA•CRITICALMG217 Multi-Symptom Treatment CreamWisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream due to Staphylococcus aureus contamination.
FDA•LOWBuspirone Hydrochloride TabletsUnichem is recalling 5 mg buspirone hydrochloride tablets due to subpotency, which may reduce the medication's effectiveness.
FDA•LOWCVS Lidocaine Wound GelCVS is recalling Lidocaine Wound Gel (NDC 59898-950, 0.5 oz) due to failed pH specifications.